Clinical trials
Liver Cirrhosis trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 16 |
| 2021 | 14 |
| 2022 | 6 |
| 2023 | 15 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
| Completed | 28 |
| Recruiting | 10 |
| Not yet recruiting | 7 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Liver and Biliary Sciences, India | 51 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 16 |
| Asian Institute of Gastroenterology, India | 2 |
| All India Institute of Medical Sciences | 1 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Azienda Ospedaliera di Padova | 1 |
| Boehringer Ingelheim | 1 |
| Chaitanya Hospital, Pune | 1 |
| Dayanand Medical College and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 83 |
| Acute-On-Chronic Liver Failure | 9 |
| Fibrosis | 7 |
| Acute Kidney Injury | 6 |
| Liver Diseases | 5 |
| Shock, Septic | 4 |
| Ascites | 3 |
| End Stage Liver Disease | 3 |
| Hepatorenal Syndrome | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
Trials
Showing 76 to 83 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.